ZA816017B - A leukocytosis-inducing protein and a process for its production and isolation - Google Patents

A leukocytosis-inducing protein and a process for its production and isolation

Info

Publication number
ZA816017B
ZA816017B ZA816017A ZA816017A ZA816017B ZA 816017 B ZA816017 B ZA 816017B ZA 816017 A ZA816017 A ZA 816017A ZA 816017 A ZA816017 A ZA 816017A ZA 816017 B ZA816017 B ZA 816017B
Authority
ZA
South Africa
Prior art keywords
serum
protein
leukorecruitin
isolation
production
Prior art date
Application number
ZA816017A
Other languages
English (en)
Inventor
Josef H Dr Wissler
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of ZA816017B publication Critical patent/ZA816017B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA816017A 1980-09-12 1981-08-31 A leukocytosis-inducing protein and a process for its production and isolation ZA816017B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3034529A DE3034529C2 (de) 1980-09-12 1980-09-12 Leukorekrutin: Ein Entzündungsmediatorprotein aus Säugerserum zur Induzierung einer Leukozytosereaktion, Herstellungsverfahren, Gewinnung in molekular einheitlicher, kristallisierbarer und biologisch spezifisch wirkender Form und Leukorekrutin enthaltendes Arzneimittel

Publications (1)

Publication Number Publication Date
ZA816017B true ZA816017B (en) 1982-08-25

Family

ID=6111831

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA816017A ZA816017B (en) 1980-09-12 1981-08-31 A leukocytosis-inducing protein and a process for its production and isolation

Country Status (9)

Country Link
US (2) US4452735A (ja)
EP (1) EP0047979B1 (ja)
JP (1) JPS5781414A (ja)
AT (1) ATE5509T1 (ja)
AU (1) AU550370B2 (ja)
CA (1) CA1168981A (ja)
DE (2) DE3034529C2 (ja)
IL (1) IL63729A (ja)
ZA (1) ZA816017B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484885A (en) * 1989-07-05 1996-01-16 Emory University Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
TW200821026A (en) * 2006-09-08 2008-05-16 Wyeth Corp Arginine wash in protein purification using affinity chromatography

Also Published As

Publication number Publication date
US4452735A (en) 1984-06-05
DE3034529C2 (de) 1982-09-23
DE3161599D1 (en) 1984-01-12
EP0047979B1 (en) 1983-12-07
ATE5509T1 (de) 1983-12-15
IL63729A0 (en) 1981-12-31
US4552761A (en) 1985-11-12
IL63729A (en) 1984-07-31
AU550370B2 (en) 1986-03-20
JPS5781414A (en) 1982-05-21
AU7465681A (en) 1982-03-18
CA1168981A (en) 1984-06-12
EP0047979A1 (en) 1982-03-24
DE3034529A1 (de) 1982-04-01

Similar Documents

Publication Publication Date Title
Lomonte et al. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo)
Mercurio et al. Glycolipids of the mouse peritoneal macrophage. Alterations in amount and surface exposure of specific glycolipid species occur in response to inflammation and tumoricidal activation.
DE68920915T2 (de) Extraktion und Reinigung einer Antigerinnungssubstanz aus den südamerikanischen Blutegeln Haementeria ghilianii.
Seegers et al. Inhibition of autoprothrombin C activity with plasma
ATE155688T1 (de) Verwendung von amylin oder cgrp zur behandlung des diabetes mellitus
Hopsu-Havu et al. Formation of bradykinin from kallidin-10 by aminopeptidase B
Pauwels et al. Induction by zinc of specific metallothionein isoforms in human monocytes
Henricks et al. Isolation and characterization of a basic keratin-like protein from mammalian spermatozoa
BE899812A (fr) Procede de preparation de concentres de proteines et de produits nutritifs par traitement de sang d'animaux.
Cicero et al. Turnover of the brain specific protein, S-100
AU550370B2 (en) Serum-derived leukorecruitin
SU1228776A3 (ru) Способ получени средства,селективно тормоз щего размножение нормальных и лейкемических клеток
US4376071A (en) Mitogenic spinal cord growth factor
IL127278A0 (en) Methods for determining the presence of brain protein s-100
Aslam et al. Two-dimensional electrophoretic analysis of proteins of bovine mammary gland secretions collected during the dry period
JPS5849319A (ja) マイトジエンおよびその単離方法
Morgan et al. Complete covalent structure of human platelet factor 4
Sato et al. Neutrophil specific 33 kDa protein: Its Ca2+‐and phospholipid‐dependent intracellular translocation
AU693800B2 (en) Diagnostic agents for osteoporosis
EP0282018A3 (en) Process for isolating basal membrane proteins from human or animal tissues
Chubb Application of Paper Chromatography to Avian Pathology: 1. The Free Amino Acids in the Blood, Urine and Body Tissues of the Normal Fowl
FR2571146B1 (fr) Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
DE3166700D1 (en) A process for producing and obtaining anaphylatoxin- and cocytotaxin-containing leucotaxine preparations and of anaphylatoxin and cocytotaxin proteins in molecularly homogeneous, biologically active form
Spry New properties and roles for eosinophils in disease: discussion paper
RU2605321C1 (ru) Фракция днк-гидролизующих секреторных иммуноглобулинов класса а, обладающая избирательной апоптотической активностью по отношению к раковым клеткам человека